Executive function is associated with balance and falls in older cancer survivors treated with chemotherapy: a cross-sectional study - McNeish BL, Dittus K, Mossburg J, Krant N, Steinharter JA, Feb K, Cote H, Hehir MK, Reynolds R, Redfern MS, Rosano C, Richardson JK, Kolb N.
INTRODUCTION: Balance decrements and increased fall risk in older cancer survivors have been attributed to chemotherapy-induced peripheral neuropathy (CIPN). Cognition is also affected by chemotherapy and may be an additional contributing factor to poor ba... (Source: SafetyLit)
Source: SafetyLit - October 2, 2023 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
Bexion Pharmaceuticals, Inc. to Participate in the 2023 Cantor Global Healthcare Conference
COVINGTON, Ky., Sept. 25, 2023 /PRNewswire/ -- Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a new generation of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN), announced today that the Company will... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 25, 2023 Category: Pharmaceuticals Source Type: news
How Many Diphtheria Vaccines are Currently Licensed in the US?
Discussion
Diphtheria is caused by the toxin produced by Corynebacterium diphtheriae. Two other Corynebacterium species (C. ulcerans and C. pseudotuberculosis) may produce diphtheria toxin; both species are zoonotic. Diphtheria is spread by respiratory droplets and also contact with open ulcers or sores. Incubation period is 1-10 days with a usual period of 2-5 days. The bacteria attacks the respiratory tract mucosa causing cellular death which in turn causes a “pseudomembrane” of tissue to build up causing respiratory distress and possible death due to airway obstruction (5-10% for general population but up to...
Source: PediatricEducation.org - September 25, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Effect of multifactorial balance rehabilitation program on risk of falls and functional fitness in older adults with diabetic peripheral neuropathy - Gupta G, Maiya GA, Bhat SN, Hande HM.
BACKGROUND: Increasing age and the added disadvantage of diabetic peripheral neuropathy (DPN) put the individual at a higher risk of falls and reduced functional fitness. However, there is a dearth of literature on multifactorial balance intervention, espe... (Source: SafetyLit)
Source: SafetyLit - August 30, 2023 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
AI could be used to detect major complications of diabetes by scanning a patient's eyes
Researchers from the University of Liverpool and Manchester Metropolitan University are tweaking equipment currently used by high street optometrists to detect diabetic peripheral neuropathy. (Source: the Mail online | Health)
Source: the Mail online | Health - August 11, 2023 Category: Consumer Health News Source Type: news
'Critically Impactful' Drug Shortages; Emotions and Cancer; CRC Clues in Microbiome
(MedPage Today) -- In a recent survey, almost a third of healthcare system pharmacists said drug shortages are "critically impacting" patient care. (CNN)
Six months of aerobic exercise helped reduce chemotherapy-induced peripheral neuropathy among... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 10, 2023 Category: Hematology Source Type: news
Aerobic Exercise Might Ease Pain for Women Who've Survived Ovarian Cancer
WEDNESDAY, Aug. 9, 2023 -- Patients being treated for ovarian cancer often experience peripheral neuropathy, a side effect from their chemotherapy that can cause both pain and numbness for months, or even years.
Now, a new study suggests that six... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 9, 2023 Category: General Medicine Source Type: news
Aerobic Exercise Cuts Chemotherapy-Induced Peripheral Neuropathy Symptoms
WEDNESDAY, Aug. 2, 2023 -- A six-month aerobic exercise intervention significantly improves self-reported chemotherapy-induced peripheral neuropathy (CIPN) among patients treated for ovarian cancer, according to a study published online Aug. 1 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 2, 2023 Category: Pharmaceuticals Source Type: news
Light Therapy May Improve Chemotherapy-Induced Neuropathy Light Therapy May Improve Chemotherapy-Induced Neuropathy
Photobiomodulation appears to improve both the severity of chemotherapy-therapy induced peripheral neuropathy, and patient mobility, a new trial suggests, but some question the study ' s validity.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - July 12, 2023 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Toxic encephalopathy and peripheral neuropathy of poisoning by Avermectin Pyridine: a case report and a review of the literature - Diao J, Zhou Q.
BACKGROUND: Avermectin Pyridaben (AVP) is an insecticide with extreme neurotoxicity in human, causing critical symptoms such as nausea, vomiting, coma and respiratory failure within a short time after oral ingestion. Neurological sequelae or even death may... (Source: SafetyLit)
Source: SafetyLit - June 24, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Janssen to Highlight Scientific Advances and Commitment to Transform Cancer Care at ASCO and EHA with More than 90 Presentations Showcasing Robust, Differentiated Portfolio and Pipeline in Hematologic Malignancies and Solid Tumors
This study evaluates an investigational combination regimen of IMBRUVICA® (ibrutinib) plus venetoclax (I+V) for newly diagnosed chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), (Abstracts #7535 and #P617, respectively).Advancing the Science of Solid Tumors Through Precision MedicineJanssen’s continued innovation in solid tumors focuses on advancing precision medicine options for patients with biomarker-driven disease who have limited targeted treatment options and moving patients into earlier lines of therapy when treatments may be more effective. Lung CancerAn oral presentation will report ...
Source: Johnson and Johnson - May 18, 2023 Category: Pharmaceuticals Tags: Innovation Source Type: news
Bariatric Surgery May Reverse Peripheral Neuropathy Bariatric Surgery May Reverse Peripheral Neuropathy
Bariatric surgery may enable peripheral nerve regeneration, making it an effective treatment for individuals with obesity at risk of diabetes and peripheral neuropathy, says a researcher.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - May 3, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Effects of motor rehabilitation on balance and functional activities in elderly patients with peripheral neuropathy and recurrent falls - Gialanella B, Comini L, Prometti P, Vanoglio F, Santoro R.
This study aimed to assess balance and the activities of daily living (ADLs) in elderly lower limb PN patient... (Source: SafetyLit)
Source: SafetyLit - May 1, 2023 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] FDA approves Roche ’s Polivy in combination with R-CHP for people with certain types of previously untreated diffuse large B-cell lymphoma
Polivy combination is the first FDA-approved therapy in nearly 20 years for the first-line treatment of diffuse large B-cell lymphoma, an aggressive disease and the most common form of non-Hodgkin lymphoma in the USPOLARIX trial showed thePolivy combination reduced the risk of disease progression, relapse or death by 27% compared to the standard of care, R-CHOP, with a comparable safety profileFirst-line treatment withPolivy plus R-CHP has the potential to reduce the burden on patients and healthcare systems, associated with disease progressionBasel, 19 April 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that t...
Source: Roche Investor Update - April 19, 2023 Category: Pharmaceuticals Source Type: news
